Logo
Whalesbook
HomeStocksNewsPremiumAbout UsContact Us

USFDA Inspections Trigger Alert: Lupin, Shilpa, Natco Pharma Stocks Face Scrutiny!

Healthcare/Biotech

|

Published on 24th November 2025, 12:55 AM

Whalesbook Logo

Author

Satyam Jha | Whalesbook News Team

Overview

Shares of Lupin Ltd., Shilpa Medicare Ltd., and Natco Pharma Ltd. are in focus after recent inspections by the US Food and Drug Administration (USFDA) resulted in observations. Alkem Laboratories Ltd. reported no critical findings from its inspection. Investors are closely watching how these companies address the regulatory feedback.